EZH2 Enzyme Linked to Drug Resistance and Tumor Growth in Prostate Cancer Researchers at Weill Cornell Medicine have uncovered a surprising role for the enzyme EZH2 in driving aggressive tumor growth in prostate cancers resistant to treatment.
EZH2 Enzyme Linked to Drug Resistance and Tumor Growth in Prostate Cancer Researchers at Weill Cornell Medicine have uncovered a surprising role for the enzyme EZH2 in driving aggressive tumor growth in prostate cancers resistant to treatment.
